NAAT

(redirected from Nucleic Acid Amplification Test)
AcronymDefinition
NAATNucleic Acid Amplification Test
NAATNucleic Acid Amplification Techniques
NAATNational Alliance Against Tolls (UK)
NAATNorth American Aviation Trilateral (Canada)
NAATNew Americans Against Tobacco
NAATNATO Anti-Armor Trials
References in periodicals archive ?
A service evaluation of the Gen-Probe APTIMA nucleic acid amplification test for Trichomonas vaginalis: should it change whom we screen for infection?
Commercial nucleic acid amplification tests in tuberculous meningitis--a meta-analysis.
The nucleic acid amplification test detects the genetic material of the virus.
mandatory individual nucleic acid amplification test (ID-NAT) testing of blood and tissue donors, quantitative hepatitis C (HCV) and hepatitis B (HBV) studies of blood donors and patients, as well as real-time PCR test for fetal RHD in plasma samples from pregnant.
25 July 2014 - Spanish healthcare company Grifols SA (NASDAQ:GRFS; BME:GRF) said Friday it had received CE mark for its Procleix HEV assay, a qualitative in-vitro nucleic acid amplification test allowing highly sensitive and specific identification of Hepatitis E virus (HEV) RNA in blood donors, blood components, tissues and organs.
Table 2: Performance of selected tests for Neisseria gonorrhoeae* Sensitivity Specificity (%; range) (%; range) Culture 85-95 100 Nucleic acid amplification test ([double dagger]) Urine specimens, LCR 94.
The in-vitro diagnostic, total nucleic acid amplification test amplifies and identifies at the same time two separate regions of the Human Immunodeficiency Virus Type 1 (HIV-1) genome, which are not subject to selective drug pressure.
Objective: Presented here is the proposal for the project - Homecare test device intime targeting to bring the first non-instrumented nucleic acid amplification test device onto the market.
Rapid HIV tests in high-income countries miss about one in seven infections and should be used in combination with fourth-generation enzyme immunoassays or nucleic acid amplification tests in clinical settings, a study showed.
While these POC tests provided quick, on-site test results, definitive diagnosis was necessarily deferred to confirmatory testing done by nucleic acid amplification tests (NAATs) in the central lab setting.
Because of this variation, published case series from individual centers demonstrating the clinical utility of quantitative nucleic acid amplification tests for many viruses are not widely applicable.